Fritextsökning
Innehållstyper
-
Astra Zeneca dumpar projekt inom blodsjukdomar – tar miljardsmäll
Astra Zeneca lägger ner ett läkemedelsprojekt inom sällsynta blodsjukdomar och tar en avsevärd ekonomisk smäll: en nedskrivning på 753 miljoner dollar, motsvara...
-
Astra Zeneca-medarbetare gripna i Kina
Fem nuvarande eller tidigare anställda hos Astra Zeneca har gripits av kinesisk polis, misstänkta för smuggling och överträdelse av Kinas dataskyddslagar
-
RegFile AB
-
Sanna Wallenborg blir ny vd på Lumito
Medicinteknikbolaget Lumito har anställt Sanna Wallenborg som ny vd.
-
Mercodia AB
-
Extremely high sample throughput rates
Precision and reliability in automated liquid handling
-
ZEISS Quality Innovations at CONTROL
May 6-9, 2025 in Stuttgart.
-
Optimize Courier SUPPLIERS (DISTRIBUTORS)
-
Nanexa develops depot formulation of the diabetes and obesity drug Saxenda
Uppsala-based company Nanexa has signed an agreement with a German contract research company to start a clinical study with a monthly depot of liraglutide. The ...
-
Lilly recruits top Swedish researcher in Alzheimer´s
One of Sweden's leading Alzheimer's researchers, Oskar Hansson, has been recruited by pharma giant Eli Lilly and will be moving to the USA.
-
Non-destructive testing and assembly control
Assess complete assembly.
-
Cost-efficient development of laboratory devices
8 ways to optimise development costs and speed up processes
-
Scientific Solutions
-
Speed meets precision for high-density components
ZEISS METROTOM 800 320 kV.
-
Marie Gårdmark: Finally, it’s time for a revision of the EU pharma legislation
A challenge for the EU Commission is to deliver a new framework that will also take care of another “pillar” of the pharmaceutical strategy, namely, to ensure that new medicines will be available for all ...
-
Swedish and Ukrainian Medical Product Agencies sign an agreement
The Directors-General of the Swedish and Ukrainian Medical Products Agencies have signed a cooperation agreement.
-
Conjugate Planes in Microscopy
Knowledge Article from ZEISS.
-
AZ gets approval for drug targeting rare disease – it may reduce cortisone dependence
AstraZeneca’s drug Fasenra gets an expanded indication in the EU and is now approved as a treatment for the rare autoimmune disease known as Churg-Strauss syndrome.
-
Double up for Korbinian Löbmann
This year, Korbinian Löbmann will moderate the New Updates in Drug Formulation & Bioavailability meeting in Copenhagen for the fifth time. Furthermore, he will ...
-
Björn Arvidsson: ”We need to change perspective”
If you say “life science” to a person on the street and ask them to explain what it is, you will probably get no good answer. The same question to your network ...
-
Lonza
-
WuXi AppTec, UK Ltd
-
High-performance Slide Scanner for Fluorescence, Brightfield and Polarization
ZEISS Axioscan 7.
-
The Oresund region aims at becoming Europe’s microbiome Mecca
The Medicon Valley Alliance’s ambition: Skåne and the Copenhagen region will become world leaders in microbiome research.